Tubulin-binding dibenz[c,e]oxepines: Part 2. Structural variation and biological evaluation as tumour vasculature disrupting agents

Bioorganic & Medicinal Chemistry
2017.0

Abstract

5,7-Dihydro-3,9,10,11-tetramethoxybenz[c,e]oxepin-4-ol 1, prepared from a dibenzyl ether precursor via Pd-catalysed intramolecular direct arylation, possesses broad-spectrum in vitro cytotoxicity towards various tumour cell lines, and induces vascular shutdown, necrosis and growth delay in tumour xenografts in mice at sub-toxic doses. The biological properties of 1 and related compounds can be attributed to their ability to inhibit microtubule assembly at the micromolar level, by binding reversibly to the same site of the tubulin αβ-heterodimer as colchicine 2 and the allocolchinol, N-acetylcolchinol 4.

Knowledge Graph

Similar Paper

Tubulin-binding dibenz[c,e]oxepines: Part 2. Structural variation and biological evaluation as tumour vasculature disrupting agents
Bioorganic & Medicinal Chemistry 2017.0
Antimitotic and antivascular activity of heteroaroyl-2-hydroxy-3,4,5-trimethoxybenzenes
Bioorganic & Medicinal Chemistry 2015.0
Allocolchicinoids bearing a Michael acceptor fragment for possible irreversible binding of tubulin
RSC Medicinal Chemistry 2020.0
Design, synthesis and bioevaluation of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-benzo[d]imidazoles as tubulin polymerization inhibitors
European Journal of Medicinal Chemistry 2021.0
Parvifoline Derivatives as Tubulin Polymerization Inhibitors
Journal of Natural Products 2019.0
Discovery of dihydrofuranoallocolchicinoids - Highly potent antimitotic agents with low acute toxicity
European Journal of Medicinal Chemistry 2020.0
Synthesis and Biological Evaluation of Furanoallocolchicinoids
Journal of Medicinal Chemistry 2015.0
Synthesis and biological evaluation of N-alkyl-N-(4-methoxyphenyl)pyridin-2-amines as a new class of tubulin polymerization inhibitors
Bioorganic & Medicinal Chemistry 2013.0
Computational modeling and target synthesis of monomethoxy-substituted o-diphenylisoxazoles with unexpectedly high antimitotic microtubule destabilizing activity
Bioorganic & Medicinal Chemistry Letters 2020.0
Oxadiazole derivatives as a novel class of antimitotic agents: Synthesis, inhibition of tubulin polymerization, and activity in tumor cell lines
Bioorganic & Medicinal Chemistry Letters 2006.0